1-15 of 21
Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Medical Industry FeatureUncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Robert F. Kushner, MD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
Beyond the Liver: The Cardiometabolic Impact of MASLD
Medical Industry FeatureBeyond the Liver: The Cardiometabolic Impact of MASLD
Nadege Gunn, MD, CPI, DABOM, FAASLD
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In MedicineNavigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Charles Turck, PharmD, BCPS, BCCCP
Andrew Freeman, MD, FACC, FACP
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Medical Industry FeatureThe Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
- advertisement
LDL-C Management in Focus: A Clinical Dialogue Between Experts
Medical Industry FeatureLDL-C Management in Focus: A Clinical Dialogue Between Experts
Jaime Burkle, MD, FACC, FNLA
M. Chadi Alraies, MD, FACC, FSCAI
Aiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Medical Industry FeatureAiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Andrew Freeman, MD, FACC, FACP
Lily Dastmalchi, DO
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Charles Turck, PharmD, BCPS, BCCCP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
- advertisement
Quick Takes in ATTR-CM: Symptoms and Comorbidities
Medical Industry FeatureQuick Takes in ATTR-CM: Symptoms and Comorbidities
Joshua Mitchell, MD, FACC
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Martha Gulati, MD, MS, FACC, FAHA
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE
